Drug-Induced Gum Overgrowth With Low-Dose Amlodipine: A Case Report
Open Access
- 22 May 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 14 (5), e25220
- https://doi.org/10.7759/cureus.25220
Abstract
Drug-induced gingival overgrowth is an adverse effect of certain drugs, including amlodipine, in genetically susceptible individuals. Although the exact mechanism of gingival hypertrophy remains unclear, a unifying multifactorial hypothesis has been constructed. Gingival hypertrophy causes difficulty in speech and mastication, poor oral hygiene, and poor aesthetic appearance. Here, we present the case of a 49-year-old woman who developed gum hypertrophy following amlodipine use for two years. Maintenance of oral hygiene and substitution of offending agent is commonly the first step in management.This publication has 17 references indexed in Scilit:
- A Rare Case Report of Amlodipine-Induced Gingival Enlargement and Review of Its PathogenesisCase Reports in Dentistry, 2013
- Network-specific mechanisms may explain the paradoxical effects of carbamazepine and phenytoinEpilepsia, 2013
- Drug-Induced Gingival OvergrowthDisease-a-Month, 2011
- The efficacy of three different surgical techniques in the management of drug‐induced gingival overgrowthJournal of Clinical Periodontology, 2006
- Informational Paper: Drug‐Associated Gingival EnlargementThe Journal of Periodontology, 2004
- Prevalence of Gingival Overgrowth Induced by Calcium Channel Blockers: A Community‐Based StudyThe Journal of Periodontology, 1999
- Determinants of gingival overgrowth severity in organ transplant patients. An examination of the role of HLA phenotypeJournal of Clinical Periodontology, 1996
- The pathogenesis of drug‐induced gingival overgrowthJournal of Clinical Periodontology, 1996
- CYCLOSPORIN, NIFEDIPINE, AND GINGIVAL HYPERPLASIAThe Lancet, 1987
- Histologic evidence for impaired growth control in diphenylhydantoin gingival overgrowth in manArchives of Oral Biology, 1978